Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-27

FDA Approved: IDARUBICIN HYDROCHLORIDE — Supplemental Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for idarubicin hydrochloride filed by Meitheal Pharmaceuticals Inc. This action completes the supplemental approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Idarubicin hydrochloride (idarubicin hydrochloride)

Snippet

SUPPL AP for IDARUBICIN HYDROCHLORIDE (IDARUBICIN HYDROCHLORIDE)